This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Biologicals S.a.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Myriam Francotte: Innovator in Herpes Simplex Vaccine Development
Introduction
Myriam Francotte is a notable inventor based in Rixensart, Belgium. She has made significant contributions to the field of vaccine development, particularly in the area of herpes simplex virus (HSV) research. Her innovative work has the potential to impact public health positively.
Latest Patents
Myriam Francotte holds a patent for a herpes simplex vaccine that comprises HSV glycoprotein gD and 3 deacylated monophosphoryl lipid A. This novel formulation aims to enhance the immune response against HSV, providing a promising avenue for future vaccine development.
Career Highlights
Francotte is associated with SmithKline Beecham Biologicals, where she has been instrumental in advancing vaccine research. Her dedication to her work has led to the development of groundbreaking solutions in the fight against viral infections.
Collaborations
Throughout her career, Myriam has collaborated with esteemed colleagues such as Jean-Paul H. Prieels and Moncef Mohamed Slaoui. These partnerships have fostered a collaborative environment that encourages innovation and scientific advancement.
Conclusion
Myriam Francotte's contributions to vaccine development, particularly in the realm of herpes simplex, highlight her role as a leading inventor in the field. Her work continues to inspire future research and innovation in vaccine technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile